Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Medicine Reports|April 5, 2014
Invadopodia are essential in transurothelial invasion during the muscle invasion of bladder cancer cellsKengo Imanishi, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.The Journal of Biological Chemistry|January 22, 2009
FBP17 Mediates a Common Molecular Step in the Formation of Podosomes and Phagocytic Cups in MacrophagesShigeru Tsuboi, Hidetoshi Takada, Toshiro Hara, et al.The Journal of Urology|March 23, 2011
Requirement for FBP17 in invadopodia formation by invasive bladder tumor cellsHayato Yamamoto, Mihoko Sutoh, Shingo Hatakeyama, et al.Molecular Medicine Reports|November 21, 2012
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunityTeppei Okamoto, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.Journal of Biochemistry|December 25, 2016
A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class IMihoko Sutoh Yoneyama, Yuki Tobisawa, Shingo Hatakeyama, et al.Oncology Research|July 25, 2013
In vivo selection of high-metastatic subline of bladder cancer cell and its characterizationNaoki Sugiyama, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.International Journal of Oncology|March 27, 2012
MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasisYuichiro Suzuki, Mihoko Sutoh, Shingo Hatakeyama, et al.Oncology Research|February 10, 2011
Invadopodia formation by bladder tumor cellsMihoko Sutoh, Yasuhiro Hashimoto, Takahiro Yoneyama, et al.The EMBO Journal|June 30, 2011
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansShigeru Tsuboi, Mihoko Sutoh, Shingo Hatakeyama, et al.Pageof 2